Clinical Trial Update: Mexiletine for the Treatment of Focal Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating mexiletine for focal dystonia, including blepharospasm, has completed. The update summarizes the trial's efficacy and safety findings…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Dystonia

Drugs mentioned

• Mexitil (mexiletine)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Blepharospasm, Dystonia | Phase 2 | Status: COMPLETED